glp-1 cardiovascular outcomes trial results august 2025 Kidney and Cardiovascular Outcomes Among Patients With CKD Receiving GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of Randomized Trials Cardiovascular Effects and Tolerability of

In the United States, for instance, just over half of employers and insurers cover GLP-1-based therapies for weight loss

Positive User Feedback Many users report reduced hunger and improved energy

Something we never in a million years thought we'd do. Christine L., 49 , 5'2" Start 211 lbs Current 158 lbs Lost 53 lbs I spent 6 months with another telehealth company and heard from them exactly twice, both times it was a billing email

In people with obesity or insulin resistance, the function of this hormone can be weaker

Adding behavioral support to ongoing medication offers the best outcomes

For example, Greek yogurt, cottage cheese, eggs, protein shakes, and tofu can all work well when a full plate of food feels overwhelming